AU2013901209A0 - Compositions and methods for the treatment of cystic fibrosis - Google Patents

Compositions and methods for the treatment of cystic fibrosis

Info

Publication number
AU2013901209A0
AU2013901209A0 AU2013901209A AU2013901209A AU2013901209A0 AU 2013901209 A0 AU2013901209 A0 AU 2013901209A0 AU 2013901209 A AU2013901209 A AU 2013901209A AU 2013901209 A AU2013901209 A AU 2013901209A AU 2013901209 A0 AU2013901209 A0 AU 2013901209A0
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
cystic fibrosis
cystic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013901209A
Inventor
Max Reynolds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2013901209A0 publication Critical patent/AU2013901209A0/en
Abandoned legal-status Critical Current

Links

AU2013901209A 2013-04-09 Compositions and methods for the treatment of cystic fibrosis Abandoned AU2013901209A0 (en)

Publications (1)

Publication Number Publication Date
AU2013901209A0 true AU2013901209A0 (en) 2013-05-02

Family

ID=

Similar Documents

Publication Publication Date Title
HK1220610A1 (en) Pyridazinone compounds and methods for the treatment of cystic fibrosis
EP2968285A4 (en) Compounds and methods for the treatment of cystic fibrosis
EP3204007A4 (en) Triazolopyridine compounds and methods for the treatment of cystic fibrosis
EP3038610A4 (en) Compositions and methods for the treatment of presbyopia
EP3030266A4 (en) Topical compositions and methods of using the same
EP3183005A4 (en) Methods and compositions for the treatment of metabolic disorders
EP3021839A4 (en) Methods and compositions for treatment of fibrosis
EP3139949A4 (en) Methods and compositions for treating cystic fibrosis
EP3008167A4 (en) Compositions and methods for treating metabolic disorders
EP3013364A4 (en) Tuberculosis compositions and methods of using the same
EP3004396A4 (en) Methods and compositions for the treatment of cancer
EP3003353A4 (en) Methods and uses of slit for treating fibrosis
IL244621A0 (en) Compositions for the treatment of hypertension and/or fibrosis
IL244622A0 (en) Compositions for the treatment of hypertension and/or fibrosis
HK1220374A1 (en) Compositions and methods for the treatment of carboxyhemoglobinemia
EP3149035A4 (en) Therapeutic compositions including therapeutic small molecules and uses thereof
EP3341006A4 (en) Compositions and methods for the treatment of neurodamage
EP2994147A4 (en) Compositions and methods for the treatment of tinnitus
EP3038596A4 (en) Compositions and methods for the removal of tattoos
EP3197470A4 (en) Cis-gnetin h and trans-gnetin h as therapeutic agents
EP3068431A4 (en) Methods and compositions for the treatment of hcmv
EP3271320A4 (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
EP3194446A4 (en) Compositions and methods for treating fibrosis
EP3055678A4 (en) Challenge sets and methods of making and using the same
AU2013901209A0 (en) Compositions and methods for the treatment of cystic fibrosis